This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract has a ceiling value of $6,106.98 and covers the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a specialty pharmaceutical product. The IDC has a total potential value of $999,999,999 and runs through November 2026, serving as a primary vehicle for the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order has no set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, is responsible for fulfilling the order, with no major subcontractors identified. The DLA, a defense agency, is the funding agency for this contract, demonstrating its role in supporting the medical needs of the U.S. military and related healthcare programs.
Generated 3/9/25, 12:58 AM